Authors/Disclosures
|
Violaine Plante-Bordeneuve, MD
(CHU Henri Mondor)
|
Dr. Plante-Bordeneuve has nothing to disclose. |
|
Teresa Coelho, MD
(Unidate Clinica de Paramoloidose Hospital)
|
Dr. Coelho has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Bryan L. Philbrook, MD
(Emory University/ Children's Healthcare of Atlanta)
|
Dr. Philbrook has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Ole Suhr
|
The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam . The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akces. The institution of Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. Ole Suhr has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Akcea. The institution of Ole Suhr has received research support from Swedish Heart and Lung Foundation. |
|
|
No disclosure on file |
|
Donna Grogan, MD
(FoldRx Pharmaceuticals/ Pfizer Pharmaceutical)
|
No disclosure on file |